Zhejiang Jiuzhou Pharm Co Ltd - Asset Resilience Ratio

Latest as of June 2022: 0.01%

Zhejiang Jiuzhou Pharm Co Ltd (603456) has an Asset Resilience Ratio of 0.01% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang Jiuzhou Pharm Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.06 Million

≈ $155.05K USD Cash + Short-term Investments

Total Assets

CN¥7.93 Billion

≈ $1.16 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2021)

This chart shows how Zhejiang Jiuzhou Pharm Co Ltd's Asset Resilience Ratio has changed over time. See 603456 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jiuzhou Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603456 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.06 Million	0.01%
Total Liquid Assets	CN¥1.06 Million	0.01%

Asset Resilience Insights

Limited Liquidity: Zhejiang Jiuzhou Pharm Co Ltd maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Jiuzhou Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jiuzhou Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd SHG:600351	Drug Manufacturers - Specialty & Generic	0.27%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	6.43%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	6.40%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Zhejiang Jiuzhou Pharm Co Ltd (2012–2021)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Jiuzhou Pharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	0.37%	CN¥26.06 Million ≈ $3.81 Million	CN¥7.04 Billion ≈ $1.03 Billion	-0.18pp
2020-12-31	0.55%	CN¥27.45 Million ≈ $4.02 Million	CN¥5.00 Billion ≈ $731.92 Million	-0.36pp
2018-12-31	0.91%	CN¥30.00 Million ≈ $4.39 Million	CN¥3.30 Billion ≈ $483.61 Million	-12.43pp
2015-12-31	13.34%	CN¥445.00 Million ≈ $65.12 Million	CN¥3.34 Billion ≈ $488.05 Million	+8.81pp
2014-12-31	4.53%	CN¥100.00 Million ≈ $14.63 Million	CN¥2.21 Billion ≈ $323.13 Million	+3.58pp
2013-12-31	0.95%	CN¥14.66 Million ≈ $2.15 Million	CN¥1.55 Billion ≈ $226.96 Million	+0.65pp
2012-12-31	0.29%	CN¥3.94 Million ≈ $577.28K	CN¥1.34 Billion ≈ $196.57 Million	--

pp = percentage points

About Zhejiang Jiuzhou Pharm Co Ltd

SHG:603456 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.79 Billion

CN¥12.27 Billion CNY

Market Cap Rank

#6683 Global

#1538 in China

Share Price

CN¥13.79

Change (1 day)

-1.22%

52-Week Range

CN¥13.75 - CN¥21.87

All Time High

CN¥60.21